Dynamic Change In Phosphorylated PDGFR In Peripheral Blood Leukocytes After Docetaxel Therapy Predicts Overall Survival In Prostate Cancer

Published on Monday 01 December 2008 - 09:00

Summary :
UroToday.com - Accurate molecular markers for targeted therapy that correlate with traditional clinical outcomes are not common. An online article from a distinguished group of researchers...
Read more

Information source

Health News from Medical News Today

http://www.medicalnewstoday.com

Website description
Medical news and health news headlines posted throughout the day, every day

Articles published on this website : 4 / 7 days - 28 / 30 days

Why Prostate Cancer Patients Fail Hormone Deprivation Two Compounds In The Trofex™ Prostate Cancer Molecular GTx Submits New Drug Application For Toremifene 80 FDA Approves Drug For Patients With Advanced Prostate Clinical Outcome Following Prostatic Capsule- And Seminal-Sparing Cystectomy

Other articles published on other websites on the same day

Prostate cancer radiotherapy safe for HIV patients http://www.reuters.com/ Prostate cancer promotes growth of new nerves http://www.newstrackindia.com/ Pulmonary Scarring on Chest X-Ray Is Associated with Lung Cancer Incidence http://rss.cancerconsultants.com/ A Preferable Test For Colon Cancer http://houston.injuryboard.com/ Nano-Targeting of Prostate Cancer http://www.medgadget.com/ Prostate cancer spurs new nerves http://www.eurekalert.org/ A Possible Cure for Down’s Syndrome?; Smoking Calcium & Vitamin D & Breast Cancer Risk http://mensnewsdaily.com/ Determinants of Change in Prostate-Specific Antigen Over Time and its Association With ... http://www.urotoday.com/ PSA after Incidental Irradiation of the Nonmalignant Prostate: Long-Term Changes - Abstract http://www.urotoday.com/